To describe the clinical features, treatment(s), and
outcomes of 15 HIV-infected patients with idiopathic Parkinson disease (PD) and
sustained virus suppression and immunologic reconstitution, from a reference
cohort of 9847 persons living with HIV (PLH).
This retrospective, single-center matched case-control 1:2
study included PLH-PD patients evaluated over a 12-year period (2002-2013) with
mean follow-up of 6.5 years. PD clinical features and dopamine replacement
therapy (DRT) were compared, and biologically relevant HIV data were assessed.
PD prevalence in PLH was similar to that of the general
population. At onset, clinical presentations and therapeutic management were
similar for both groups. Rapidly effective DRT was well tolerated without
combined antiretroviral therapy interactions or virus escape. At the end of the
follow-up, compared with HIV-negative PD, PLH had a significantly lower median
Unified Parkinson's Disease Rating Scale motor score (4 vs 14; P < 0.001),
median Hoehn and Yahr stage (1 vs 2; P = 0.0005), and median Handipark scale
score (2 vs 3; P = 0.0036) under the same daily DRT. One PLH underwent highly
successful deep brain stimulation of the subthalamic nucleus.
HIV-associated PD is similar to idiopathic PD with some
features suggesting an HIV-induced functional adaptation of dopaminergic
neurons that might counterbalance the PD-induced neuronal loss. Concurrent HIV
infection does not compromise the outcome of idiopathic PD.
- 1*Service de Neurologie, Fondation Adolphe de Rothschild, Paris, France; †Service des Maladies Infectieuses et Tropicales, AP-HP, Hôpital Tenon, Paris, France; ‡Service des Maladies Infectieuses et Tropicales, AP-HP, Hôpital Saint Louis, Paris, France; §Service des Maladies Infectieuses et Tropicales, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France; ‖INSERM, IAME, UMR 1137, Paris, France; ¶Unité James Parkinson, Service de Neurologie, Fondation Adolphe de Rothschild, Paris, France; #Service des Maladies Infectieuses et Tropicales, AP-HP, Hôpital Saint Antoine, Paris, France; **Université Pierre et Marie Curie, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière (CRICM), UMRS 975, Equipe "Alzheimer's and Prion Diseases," Paris, France; ††Département d'Ophtalmologie, Fondation Adolphe de Rothschild, Paris, France; and ‡‡Service d'Ophtalmologie, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France.
More at:
https://twitter.com/hiv_insight
No comments:
Post a Comment